192 results
8-K
EX-99.1
INVA
Innoviva Inc
13 May 24
Corporate Presentation May 2024
9:27am
– a serious complication, particularly for ICU patients Positioned to avoid common stewardship and access concerns Other branded antibiotics push … continues to rise Unique patient populations Other populations where stockable oral therapies would be preferred due to uneven access to healthcare
DEFA14A
INVA
Innoviva Inc
29 Apr 24
Additional proxy soliciting materials
5:30pm
to you on the Internet. This is not a ballot. You cannot use this notice to vote your shares. We encourage you to access and review all of the important … make this request on or before June 5, 2024.
Your control number
Have the 12 digit control number located in the box above available when you access
8-K
EX-10.1
j8mfv5qq
25 Aug 23
Innoviva Appoints Stephen Basso as Chief Financial Officer
5:24pm
8-K
EX-99.1
ypvt8wnd ze
24 May 23
Corporate Presentation May 2023
5:18pm
DEFA14A
hgyodqu3 3e2x
17 May 23
Additional proxy soliciting materials
5:18pm
8-K
EX-99.1
38wz50gw31359jmi
14 Sep 22
Regulation FD Disclosure
5:22pm
8-K
EX-99.1
rhzqoa6
23 Aug 22
Other Events
4:08pm
SC TO-T
EX-99
5w0ugw7lrtu3fv
25 Jul 22
Third party tender offer statement
8:34am
8-K
EX-10.1
keocfr2la6ldtbtug
13 Jul 22
Entry into a Material Definitive Agreement
5:27pm